ACC.22: ACC’s 71st Annual Scientific Session & Expo

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Washington, DC, United States
Apr 02, 2022 - Apr 04, 2022
Connect with your peers and top experts in the field to get the latest practice-changing research and cutting-edge education designed to transform cardiovascular care for you, for your team, and for your patients.
Visit the conference website for more details.

News

ACC 2022: Novel Perioperative Hypotension Avoidance Strategy Has No Impact on Vascular Complications

PracticeUpdate Editorial Team · April 17, 2022

ACC.22
ACC 2022: Sodium Thiosulfate Fails to Reduce Myocardial Injury in STEMI Patients

PracticeUpdate Editorial Team · April 17, 2022

ACC.22
ACC 2022: FIDELITY Demonstrates Benefits of Finerenone in the Primary and Secondary Prevention Settings

PracticeUpdate Editorial Team · April 17, 2022

ACC.22
ACC 2022: EMPULSE Analysis Reveals Consistent Benefits for Empagliflozin in Heart Failure Regardless of Impairment at Baseline

PracticeUpdate Editorial Team · April 17, 2022

ACC.22
ACC 2022: Fractional Flow Noninferior to Ultrasound-Guided Strategy for Intermediate Coronary Stenosis

PracticeUpdate Editorial Team · April 16, 2022

ACC.22
ACC 2022: PROTECT Reveals No Benefit to Aggressive Warming During Surgery

PracticeUpdate Editorial Team · April 16, 2022

ACC.22
ACC 2022: Pregnant Women With Mild Hypertension Benefit From Antihypertensive Therapy

PracticeUpdate Editorial Team · April 13, 2022

ACC.22
ACC 2022: Complete Revascularization May Improve Quality of Life in STEMI Patients With Multivessel Disease More Than a Culprit-Only Approach

PracticeUpdate Editorial Team · April 13, 2022

ACC.22
ACC 2022: Diltiazem Fails to Improve Coronary Vasomotor Dysfunction on Cardiac Function Testing

PracticeUpdate Editorial Team · April 13, 2022

ACC ACC.22
ACC 2022: Plaque Stabilization and Regression Possible in Acute Coronary Syndromes With PCSK9 inhibitor Plus High-Intensity Statins

PracticeUpdate Editorial Team · April 12, 2022

ACC.22

Notice to Our Valued Users

ACC.22: ACC’s 71st Annual Scientific Session & Expo

News

ACC 2022: Novel Perioperative Hypotension Avoidance Strategy Has No Impact on Vascular Complications

ACC 2022: Sodium Thiosulfate Fails to Reduce Myocardial Injury in STEMI Patients

ACC 2022: FIDELITY Demonstrates Benefits of Finerenone in the Primary and Secondary Prevention Settings

ACC 2022: EMPULSE Analysis Reveals Consistent Benefits for Empagliflozin in Heart Failure Regardless of Impairment at Baseline

ACC 2022: Fractional Flow Noninferior to Ultrasound-Guided Strategy for Intermediate Coronary Stenosis

ACC 2022: PROTECT Reveals No Benefit to Aggressive Warming During Surgery

ACC 2022: Pregnant Women With Mild Hypertension Benefit From Antihypertensive Therapy

ACC 2022: Complete Revascularization May Improve Quality of Life in STEMI Patients With Multivessel Disease More Than a Culprit-Only Approach

ACC 2022: Diltiazem Fails to Improve Coronary Vasomotor Dysfunction on Cardiac Function Testing

ACC 2022: Plaque Stabilization and Regression Possible in Acute Coronary Syndromes With PCSK9 inhibitor Plus High-Intensity Statins

No Content

Recently Updated